KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Other financing activities (2016 - 2026)

Pfizer has reported Other financing activities over the past 18 years, most recently at -$284.0 million for Q1 2026.

  • Quarterly Other financing activities rose 20.22% to -$284.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$386.0 million through Mar 2026, up 69.37% year-over-year, with the annual reading at -$458.0 million for FY2025, 2.35% up from the prior year.
  • Other financing activities was -$284.0 million for Q1 2026 at Pfizer, down from -$43.0 million in the prior quarter.
  • Over five years, Other financing activities peaked at $154.0 million in Q3 2022 and troughed at -$501.0 million in Q2 2022.
  • The 5-year median for Other financing activities is -$140.0 million (2023), against an average of -$197.7 million.
  • Year-over-year, Other financing activities plummeted 1129.73% in 2024 and then surged 91.65% in 2025.
  • A 5-year view of Other financing activities shows it stood at -$342.0 million in 2022, then surged by 94.74% to -$18.0 million in 2023, then plummeted by 2427.78% to -$455.0 million in 2024, then skyrocketed by 90.55% to -$43.0 million in 2025, then crashed by 560.47% to -$284.0 million in 2026.
  • Per Business Quant, the three most recent readings for PFE's Other financing activities are -$284.0 million (Q1 2026), -$43.0 million (Q4 2025), and -$38.0 million (Q3 2025).